Design, synthesis, and biological evaluation of Osimertinib–Cy7 (OSA-Cy7) conjugate as potential theranostic agent targeting activating EGFR mutations
发布日期：2026/10/27 13:43:35
购物车0
产品总数：56533
(C)C4C(%3dCC%3dCC%3d4)%5bN%2b%5d%3d3C)%3dC2)C(C)(C)C2C1%3dCC%3dCC%3d2)%3dO)
沪公网安备31011402010657号